MMP9 and colorectal carcinoma: Ezetimibe induced MMP-2 and MMP-9 downregulation in HCT116 and Caco2 cells (Figures 4A, B); this finding, together with the decreased wounding healing capacity found in the scratch assay, demonstrated the inhibitory effects of ezetimibe against CRC invasiveness.